We are live on ! Find out more
LFCR icon

Lifecore Biomedical
LFCR

78 hedge funds and large institutions have $136M invested in Lifecore Biomedical in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 10

87% more call options, than puts

Call options by funds: $954K | Put options by funds: $509K

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

13% more funds holding

Funds holding: 69 → 78 (+9)

7.12% more ownership

Funds ownership: 65.45% → 72.57% (+7.1%)

3% more capital invested

Capital invested by funds: $132M → $136M (+$3.72M)

0% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 18

Holders
78
Holders Change
+9
Holders Change %
+13.04%
% of All Funds
1.14%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
19
Increased
18
Reduced
18
Closed
10
Calls
$954K
Puts
$509K
Net Calls
+$445K
Net Calls Change
+$282K

Top Buyers

Rank Fund Capital Flow
1
3C
325 Capital
New York
+$8.38M
2
Morgan Stanley
Morgan Stanley
New York
+$5.43M
3
Deutsche Bank
Deutsche Bank
Germany
+$2.19M
4
GRIM
Greenhaven Road Investment Management
Connecticut
+$1.21M
5
DA
DCF Advisers
Connecticut
+$965K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.43M
2
Verition Fund Management
Verition Fund Management
Connecticut
-$2.36M
3
CSC
Cove Street Capital
California
-$1.36M
4
HT
HAP Trading
New York
-$1.24M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$758K
Name Holding Trade Value Shares
Change 		Change in
Stake
GI
26
GAMCO Investors
Connecticut
$474K – – –
UBS Group
27
UBS Group
Switzerland
$469K -$40K -5,767 -7%
RA
28
Royce & Associates
New York
$468K – – –
Balyasny Asset Management
29
Balyasny Asset Management
Illinois
$459K +$515K +74,180 New
USPCM
30
Union Square Park Capital Management
New York
$429K +$481K +69,340 New
Northern Trust
31
Northern Trust
Illinois
$382K -$10.5K -1,508 -2%
American Century Companies
32
American Century Companies
Missouri
$345K -$10.3K -1,483 -3%
DC
33
Diametric Capital
Massachusetts
$332K +$373K +53,702 New
DT
34
Diversified Trust
Tennessee
$285K – – –
Renaissance Technologies
35
Renaissance Technologies
New York
$227K -$226K -32,600 -47%
Bank of America
36
Bank of America
North Carolina
$213K +$24.6K +3,543 +11%
Goldman Sachs
37
Goldman Sachs
New York
$208K +$157K +22,558 +204%
6CM
38
683 Capital Management
New York
$195K +$218K +31,456 New
OAM
39
Oppenheimer Asset Management
New York
$148K -$66.8K -9,625 -29%
Assenagon Asset Management
40
Assenagon Asset Management
Luxembourg
$148K – – –
PCM
41
Prelude Capital Management
New York
$141K +$158K +22,745 New
KA
42
Keene & Associates
Texas
$136K -$13.9K -2,000 -8%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$127K -$28.1K -4,048 -16%
Barclays
44
Barclays
United Kingdom
$121K -$79.2K -11,403 -37%
HF
45
HRT Financial
New York
$119K +$134K +19,353 New
ECM
46
ExodusPoint Capital Management
New York
$116K +$130K +18,700 New
GF
47
Gabelli Funds
New York
$113K +$11.8K +1,700 +10%
PWPS
48
Pinnacle Wealth Planning Services
Ohio
$110K -$7.85K -1,131 -6%
JFG
49
Jefferies Financial Group
New York
$110K – – –
EGM
50
Engineers Gate Manager
New York
$106K +$18.2K +2,615 +18%
1
2
3 4

LFCR Hedge Fund Activity: Q4 2023 in Review

78 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q4 2023, worth a combined $136M — up 2.8% from $132M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new LFCR positions and 10 closed out — a net gain of 9 holders — while 18 added to existing stakes and 18 trimmed.

The largest buyer was 325 Capital, opening a new position worth an estimated $8.38M. The largest seller was Millennium Management, cutting an estimated $2.43M.

  • 78 institutional investors held Lifecore Biomedical (LFCR) as of Q4 2023, up from 69 in Q3 2023.
  • Funds reported $136M of Lifecore Biomedical stock for Q4 2023, up 2.8% quarter-over-quarter.
  • 19 funds opened new Lifecore Biomedical positions in Q4 2023 and 10 closed out, a net change of +9 holders.
  • The largest Lifecore Biomedical buyer in Q4 2023 was 325 Capital, an estimated $8.38M added.
  • The largest Lifecore Biomedical seller in Q4 2023 was Millennium Management, an estimated $2.43M sold.

Based on aggregated 13F filings for Q4 2023.